84 related articles for article (PubMed ID: 19423214)
21. Allo-restricted CTLs generated by coculturing of PBLs and autologous monocytes loaded with allogeneic peptide/HLA/IgG1-Fc fusion protein.
Weng X; Lu S; Zhong M; Liang Z; Shen G; Chen J; Wu X
J Leukoc Biol; 2009 Mar; 85(3):574-81. PubMed ID: 19112092
[TBL] [Abstract][Full Text] [Related]
22. Efficient identification of a novel cancer/testis antigen for immunotherapy using three-step microarray analysis.
Yokoe T; Tanaka F; Mimori K; Inoue H; Ohmachi T; Kusunoki M; Mori M
Cancer Res; 2008 Feb; 68(4):1074-82. PubMed ID: 18281482
[TBL] [Abstract][Full Text] [Related]
23. Combining MHC tetramer and intracellular cytokine staining for CD8(+) T cells to reveal antigenic epitopes naturally presented on tumor cells.
Dimopoulos N; Jackson HM; Ebert L; Guillaume P; Luescher IF; Ritter G; Chen W
J Immunol Methods; 2009 Jan; 340(1):90-4. PubMed ID: 18957296
[TBL] [Abstract][Full Text] [Related]
24. Fine structural variations of alphabetaTCRs selected by vaccination with natural versus altered self-antigen in melanoma patients.
Wieckowski S; Baumgaertner P; Corthesy P; Voelter V; Romero P; Speiser DE; Rufer N
J Immunol; 2009 Oct; 183(8):5397-406. PubMed ID: 19786555
[TBL] [Abstract][Full Text] [Related]
25. Use of immobilized HLA-A2:Ig dimeric proteins to determine the level of epitope-specific, HLA-restricted CD8(+) T-cell response.
Horowitz A; Li X; Poles MA; Tsuji M
Scand J Immunol; 2009 Nov; 70(5):415-22. PubMed ID: 19874545
[TBL] [Abstract][Full Text] [Related]
26. Identification and validation of T-cell epitopes using the IFN-gamma ELISPOT assay.
Wulf M; Hoehn P; Trinder P
Methods Mol Biol; 2009; 524():439-46. PubMed ID: 19377964
[TBL] [Abstract][Full Text] [Related]
27. [Identification of a naturally presented MAGE-A3 epitope on the surface of HLE cell line by mass spectrometry].
Peng JR; Dong N; Liu HW; Leng XS
Zhonghua Wai Ke Za Zhi; 2007 May; 45(9):595-7. PubMed ID: 17688791
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal immune monitoring of patients receiving intratumoral injection of a MART-1 T-cell receptor-transduced cell line (C-Cure 709).
Køllgaard T; Duval L; Schmidt H; Kaltoft K; Seremet T; Andersen MH; Maase Hv; Straten Pt; Hadrup SR
Cytotherapy; 2009; 11(5):631-41. PubMed ID: 19530030
[TBL] [Abstract][Full Text] [Related]
29. HLA-B27-restricted antigen presentation by human chondrocytes to CD8+ T cells: potential contribution to local immunopathologic processes in ankylosing spondylitis.
Kuhne M; Erben U; Schulze-Tanzil G; Köhler D; Wu P; Richter FJ; John T; Radbruch A; Sieper J; Appel H
Arthritis Rheum; 2009 Jun; 60(6):1635-46. PubMed ID: 19479861
[TBL] [Abstract][Full Text] [Related]
30. High frequencies of functionally competent circulating Tax-specific CD8+ T cells in human T lymphotropic virus type 2 infection.
Oliveira AL; Hayakawa H; Schor D; Leite AC; Espíndola OM; Waters A; Dean J; Doherty DG; Araújo AQ; Hall WW
J Immunol; 2009 Sep; 183(5):2957-65. PubMed ID: 19657093
[TBL] [Abstract][Full Text] [Related]
31. IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities.
Ho MY; Leu SJ; Sun GH; Tao MH; Tang SJ; Sun KH
J Immunol; 2009 Nov; 183(10):6217-26. PubMed ID: 19841177
[TBL] [Abstract][Full Text] [Related]
32. Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes.
Kloverpris H; Karlsson I; Bonde J; Thorn M; Vinner L; Pedersen AE; Hentze JL; Andresen BS; Svane IM; Gerstoft J; Kronborg G; Fomsgaard A
AIDS; 2009 Jul; 23(11):1329-40. PubMed ID: 19528789
[TBL] [Abstract][Full Text] [Related]
33. Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3.
Piesche M; Hildebrandt Y; Chapuy B; Wulf GG; Trümper L; Schroers R
Vaccine; 2009 Jul; 27(34):4718-23. PubMed ID: 19446593
[TBL] [Abstract][Full Text] [Related]
34. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
35. The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum.
Westwood JA; Murray WK; Trivett M; Haynes NM; Solomon B; Mileshkin L; Ball D; Michael M; Burman A; Mayura-Guru P; Trapani JA; Peinert S; Hönemann D; Miles Prince H; Scott AM; Smyth MJ; Darcy PK; Kershaw MH
J Immunother; 2009 Apr; 32(3):292-301. PubMed ID: 19242371
[TBL] [Abstract][Full Text] [Related]
36. Identification of HLA-A24 restricted pre-erythrocytic stage specific T-cell epitopes using Plasmodium falciparum synthetic peptides: a preliminary study.
Tippawangkosol P; Duangchanda T; Ubalee R; Ruengweerayut R; Hirayama K; Na-Bangchang K
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):10-7. PubMed ID: 19323028
[TBL] [Abstract][Full Text] [Related]
37. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
[TBL] [Abstract][Full Text] [Related]
38. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
[TBL] [Abstract][Full Text] [Related]
39. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
40. Ii-Key/HPV16 E7 hybrid peptide immunotherapy for HPV16+ cancers.
Xu M; Lu X; Sposato M; Zinckgraf JW; Wu S; von Hofe E
Vaccine; 2009 Jul; 27(34):4641-7. PubMed ID: 19520206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]